TRIM family contribute to tumorigenesis, cancer development, and drug resistance DOI Creative Commons
Ning Huang, Xiaolin Sun, Peng Li

et al.

Experimental Hematology and Oncology, Journal Year: 2022, Volume and Issue: 11(1)

Published: Oct. 19, 2022

Abstract The tripartite-motif (TRIM) family represents one of the largest classes putative single protein RING-finger E3 ubiquitin ligases. TRIM is involved in a variety cellular signaling transductions and biological processes. also contributes to cancer initiation, progress, therapy resistance, exhibiting oncogenic tumor-suppressive functions different human types. Moreover, members have great potential serve as biomarkers for diagnosis prognosis. In this review, we focus on specific mechanisms participation tumorigenesis, development including interacting with dysregulated pathways such JAK/STAT, PI3K/AKT, TGF-β, NF-κB, Wnt/β-catenin, p53 hub. addition, many studies demonstrated that are related tumor resistance; modulate epithelial–mesenchymal transition (EMT) process, guarantee acquisition stem cells (CSCs) phenotype. end, havediscussed therapeutic targets.

Language: Английский

The sirtuin family in health and disease DOI Creative Commons
Qi‐Jun Wu, Tie‐Ning Zhang, Huanhuan Chen

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2022, Volume and Issue: 7(1)

Published: Dec. 29, 2022

Sirtuins (SIRTs) are nicotine adenine dinucleotide(+)-dependent histone deacetylases regulating critical signaling pathways in prokaryotes and eukaryotes, involved numerous biological processes. Currently, seven mammalian homologs of yeast Sir2 named SIRT1 to SIRT7 have been identified. Increasing evidence has suggested the vital roles members SIRT family health disease conditions. Notably, this protein plays a variety important cellular biology such as inflammation, metabolism, oxidative stress, apoptosis, etc., thus, it is considered potential therapeutic target for different kinds pathologies including cancer, cardiovascular disease, respiratory other Moreover, identification modulators exploring functions these prompted increased efforts discover new small molecules, which can modify activity. Furthermore, several randomized controlled trials indicated that interventions might affect expression human samples, supplementation diverse impact on physiological function participants. In review, we introduce history structure family, discuss molecular mechanisms elaborate regulatory SIRTs summarize inhibitors activators, review related clinical studies.

Language: Английский

Citations

427

The Hippo signalling pathway and its implications in human health and diseases DOI Creative Commons

Minyang Fu,

Yuan Hu,

Tianxia Lan

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2022, Volume and Issue: 7(1)

Published: Nov. 8, 2022

Abstract As an evolutionarily conserved signalling network, the Hippo pathway plays a crucial role in regulation of numerous biological processes. Thus, substantial efforts have been made to understand upstream signals that influence activity pathway, as well its physiological functions, such cell proliferation and differentiation, organ growth, embryogenesis, tissue regeneration/wound healing. However, dysregulation can cause variety diseases, including cancer, eye cardiac pulmonary renal hepatic immune dysfunction. Therefore, therapeutic strategies target dysregulated components might be promising approaches for treatment wide spectrum diseases. Here, we review key critical functions controlled by pathway. Additionally, diseases associated with alterations potential therapies targeting will discussed.

Language: Английский

Citations

353

Metabolic programming and immune suppression in the tumor microenvironment DOI Creative Commons
Emily N. Arner, Jeffrey C. Rathmell

Cancer Cell, Journal Year: 2023, Volume and Issue: 41(3), P. 421 - 433

Published: Feb. 16, 2023

Language: Английский

Citations

278

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer DOI Creative Commons
Richard Cunningham, Carsten Gram Hansen

Clinical Science, Journal Year: 2022, Volume and Issue: 136(3), P. 197 - 222

Published: Feb. 1, 2022

Abstract Tumorigenesis is a highly complex process, involving many interrelated and cross-acting signalling pathways. One such pathway that has garnered much attention in the field of cancer research over last decade Hippo pathway. Consisting two antagonistic modules, plays an integral role both tumour suppressive oncogenic processes, generally via regulation diverse set genes involved range biological functions. This review discusses history within context explores some most recent discoveries as to how this critical transducer cellular can influence progression. A special focus on various efforts therapeutically target key effectors preclinical clinical settings.

Language: Английский

Citations

221

Molecular mechanisms of tumor resistance to radiotherapy DOI Creative Commons
Yu Wu, Yingqiu Song, Runze Wang

et al.

Molecular Cancer, Journal Year: 2023, Volume and Issue: 22(1)

Published: June 15, 2023

Abstract Background Cancer is the most prevalent cause of death globally, and radiotherapy considered standard care for solid tumors, including lung, breast, esophageal, colorectal cancers glioblastoma. Resistance to radiation can lead local treatment failure even cancer recurrence. Main body In this review, we have extensively discussed several crucial aspects that resistance therapy, radiation-induced DNA damage repair, cell cycle arrest, apoptosis escape, abundance stem cells, modification cells their microenvironment, presence exosomal non-coding RNA, metabolic reprogramming, ferroptosis. We aim focus on molecular mechanisms in relation these discuss possible targets improve outcomes. Conclusions Studying responsible its interactions with tumor environment will help responses radiotherapy. Our review provides a foundation identify overcome obstacles effective

Language: Английский

Citations

217

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials DOI Creative Commons
Hao Zhang,

Xinghai Yue,

Zhe Chen

et al.

Molecular Cancer, Journal Year: 2023, Volume and Issue: 22(1)

Published: Oct. 2, 2023

Abstract Despite centuries since the discovery and study of cancer, cancer is still a lethal intractable health issue worldwide. Cancer-associated fibroblasts (CAFs) have gained much attention as pivotal component tumor microenvironment. The versatility sophisticated mechanisms CAFs in facilitating progression been elucidated extensively, including promoting angiogenesis metastasis, inducing drug resistance, reshaping extracellular matrix, developing an immunosuppressive Owing to their robust tumor-promoting function, are considered promising target for oncotherapy. However, highly heterogeneous group cells. Some subpopulations exert inhibitory role growth, which implies that CAF-targeting approaches must be more precise individualized. This review comprehensively summarize origin, phenotypical, functional heterogeneity CAFs. More importantly, we underscore advances strategies clinical trials CAF various cancers, also progressions immunotherapy.

Language: Английский

Citations

174

Designing bioresponsive nanomaterials for intracellular self-assembly DOI Open Access
Sarah Chagri, David Y. W. Ng, Tanja Weil

et al.

Nature Reviews Chemistry, Journal Year: 2022, Volume and Issue: 6(5), P. 320 - 338

Published: April 1, 2022

Language: Английский

Citations

166

Artificial intelligence-based multi-omics analysis fuels cancer precision medicine DOI Open Access
Xiujing He, Xiaowei Liu,

Fengli Zuo

et al.

Seminars in Cancer Biology, Journal Year: 2022, Volume and Issue: 88, P. 187 - 200

Published: Dec. 31, 2022

Language: Английский

Citations

164

Molecular basis for redox control by the human cystine/glutamate antiporter system xc− DOI Creative Commons
Joanne L. Parker, Justin C. Deme, Dimitrios Kolokouris

et al.

Nature Communications, Journal Year: 2021, Volume and Issue: 12(1)

Published: Dec. 8, 2021

Cysteine plays an essential role in cellular redox homoeostasis as a key constituent of the tripeptide glutathione (GSH). A rate limiting step GSH synthesis is availability cysteine. However, circulating cysteine exists blood oxidised di-peptide cystine, requiring specialised transport systems for its import into cell. System xc

Language: Английский

Citations

154

Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective DOI Creative Commons
Yang Yang, Shuo Li, Yujiao Wang

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2022, Volume and Issue: 7(1)

Published: Sept. 17, 2022

Abstract Protein tyrosine kinases (PTKs) are a class of proteins with kinase activity that phosphorylate residues critical molecules in signaling pathways. Their basal function is essential for maintaining normal cell growth and differentiation. However, aberrant activation PTKs caused by various factors can deviate from the expected trajectory to an abnormal state, leading carcinogenesis. Inhibiting PTK could inhibit tumor growth. Therefore, inhibitors (TKIs), target-specific PTKs, have been used treating malignant tumors play significant role targeted therapy cancer. Currently, drug resistance main reason limiting TKIs efficacy The increasing studies indicated microenvironment, death resistance, metabolism, epigenetic modification metabolism were deeply involved development TKI besides PTK-related pathways gene mutations. Accordingly, it great significance study underlying mechanisms find solutions reverse improving Herein, we reviewed potential approaches overcome aiming provide theoretical basis TKIs.

Language: Английский

Citations

154